Copyright
©The Author(s) 2022.
World J Gastroenterol. Mar 21, 2022; 28(11): 1159-1171
Published online Mar 21, 2022. doi: 10.3748/wjg.v28.i11.1159
Published online Mar 21, 2022. doi: 10.3748/wjg.v28.i11.1159
Variables | Non-BSI, n = 272 | BSI, n = 106 | Multivariate analysis | |||||
Median or n | (IQR) or (%) | Median or n | (IQR) or (%) | P value1 | ORs | 95%CI | P value | |
Age | 1.83 | (0.86-6.0) | 1.17 | (0.75-3.08) | 0.005 | 2.1 | (1.18-3.77) | 0.011 |
Sex, male | 124 | (45.6) | 52 | (49) | 0.544 | |||
Height, z-score | -0.66 | (-1.60-0.34) | -1.23 | (-2.17-0.0) | 0.005 | 1.1 | (0.54-2.37) | 0.722 |
Weight, z-score | -0.07 | (-1.04-0.71) | -0.53 | (-1.7-0.4) | 0.002 | 1.2 | (0.70-2.25) | 0.438 |
Growth failure | 52 | (19) | 42 | (40) | < 0.001 | 2.1 | (1.01-4.47) | 0.045 |
Diagnosis: Biliary atresia | 134 | (49) | 66 | (62) | 0.023 | 1.2 | (0.66-2.15) | 0.546 |
Ventilator | 14 | (5.1) | 11 | (10) | 0.066 | |||
Renal replacement | 11 | (4.0) | 8 | (7.5) | 0.161 | |||
Liver support system | 10 | (3.7) | 10 | (9.4) | 0.025 | 4.2 | (1.45-12.09) | 0.008 |
PELD | 16.2 | (6.40-23.7) | 15.5 | (10.6-24.3) | 0.209 | |||
MELD | 27.1 | (11.3-32.3) | 29 | (27.8-29.7) | 0.746 | |||
LT, DDLT | 71 | (26) | 20 | (19) | 0.139 | |||
ABO mismatch | 8 | (2.9) | 3 | (2.8) | 0.954 | |||
Operation time, min | 417 | (357-536) | 411 | (350-507) | 0.408 | |||
RBC transfusion, cc/kg | 17.4 | (7.6-29.5) | 25.7 | (9.8-42.1) | 0.003 | 1.5 | (0.87-2.50) | 0.146 |
Post-LT hospital stay | 36 | (26-50) | 41 | (28-67) | 0.002 | 2.3 | (1.35-3.91) | 0.002 |
Donor, male | 128 | (47) | 44 | (42) | 0.33 | |||
Donor, body mass index | 22.3 | (20.3-24.4) | 22.7 | (21.1-24.5) | 0.267 | |||
Reoperation | 29 | (11) | 21 | (20) | 0.018 | 1.30 | (0.64-2.61) | 0.470 |
Hepatic artery complication | 2 | (0.7) | 2 | (2.0) | 0.326 | |||
Hepatic vein complication | 24 | (8.8) | 15 | (14) | 0.126 | |||
Portal vein complication | 27 | (9.9) | 24 | (23) | 0.001 | 1.85 | (0.95-3.59) | 0.070 |
Bile duct complication | 16 | (5.9) | 5 | (4.7) | 0.657 | |||
Cytomegalovirus infection | 161 | (59) | 61 | (58) | 0.771 | |||
Epstein–Barr virus infection | 187 | (69) | 72 | (68) | 0.839 | |||
Acute cellular rejection | 127 | (47) | 59 | (56) | 0.117 |
- Citation: Kim YE, Choi HJ, Lee HJ, Oh HJ, Ahn MK, Oh SH, Namgoong JM, Kim DY, Jhang WK, Park SJ, Jung DH, Moon DB, Song GW, Park GC, Ha TY, Ahn CS, Kim KH, Hwang S, Lee SG, Kim KM. Assessment of pathogens and risk factors associated with bloodstream infection in the year after pediatric liver transplantation. World J Gastroenterol 2022; 28(11): 1159-1171
- URL: https://www.wjgnet.com/1007-9327/full/v28/i11/1159.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i11.1159